RealTalk MS

Jon Strum
  • 0.0(0개의 평가)
  • 의학
  • 매주 업데이트

Jon Strum cuts through all the jargon and breaks down the latest multiple sclerosis news. You'll meet the scientists who are creating tomorrow's MS treatments today. You'll hear from the experts discussing how the latest tweaks and changes to our healthcare laws will impact your MS treatment. And we'll be talking to the courageous MS warriors who are out there advocating on behalf of the MS community every day, as well as the men and women who are committed to living their best lives with MS and living their best lives as MS caregivers. If you're dealing with multiple sclerosis in your life -- as a patient, caregiver, family member, or friend -- join us each week for RealTalk MS.

  1. Episode 462: Taking Your MS to College? Understand Your Right to Accommodation with Britt Neff

    16시간 전

    Episode 462: Taking Your MS to College? Understand Your Right to Accommodation with Britt Neff

    The Americans with Disabilities Act ensures that people living with disabilities receive reasonable accommodations at work. That law also applies to students attending most colleges and universities. And the ADA doesn't limit itself to physical disabilities. It's often applied to invisible disabilities, as well. This week, Britt Neff, the Access Specialist at the University of Washington School of Law, joins me to explain all the ways the accommodation process can work for college students living with MS.   We'll also tell you about PTD802, an oral remyelination therapy that's just been given a green light from the FDA to begin human clinical trials We're sharing evidence from an important study that should make you feel more confident about getting those MMR (measles, mumps, rubella) and chickenpox vaccines. You'll learn what researchers at the Cleveland Clinic discovered when they asked the question, "Can someone living with MS over the age of 60 discontinue their disease-modifying therapy?" And we're sharing the details about an AI application that can predict -- with 90% accuracy -- whether someone with MS is at risk of experiencing cognitive decline over the next few years.  We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Understanding "reasonable accommodation" at college  :22 FDA approves oral remyelination therapy PTD802 for Phase 1 clinical trial  1:07 Study results: MMR (measles, mumps, rubella) and chickenpox vaccines are shown to be safe for people with MS  4:52 Study results: Is it safe for someone living with MS over 60 to discontinue their DMT?   7:34 Study results: AI predicts future cognitive changes among people with MS with 90% accuracy   10:45 Britt Neff explains the many types of accommodation available to college students with MS  15:01 Share this episode  28:24 Next week  28:44 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/462 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com Pheno Therapeutics https://phenotherapeutics.com STUDY: Live Attenuated MMR and Varicella Vaccinations and Multiple Sclerosis Activity https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2849165 STUDY: Long-Term Follow-Up of Patients with Multiple Sclerosis Over Age 60: Comparing Clinical and Radiological Outcomes in Disease-Modifying Therapy Continuers and Discontinuers https://journals.sagepub.com/doi/full/10.1177/20552173261448005 STUDY: Explainable Artificial Intelligence to Predict Neurocognitive Disorder Progression in Multiple Sclerosis Using MRI and Clinical Data https://onlinelibrary.wiley.com/doi/10.1111/ene.70568 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 462 Guest: Britt Neff Privacy Policy

    30분
  2. A New Disease-Modifying Therapy Has Been Submitted for FDA Approval with Dr. Jiwon Oh

    6월 29일

    A New Disease-Modifying Therapy Has Been Submitted for FDA Approval with Dr. Jiwon Oh

    A short while ago, we shared very positive results from the Phase 3 clinical trials for fenebrutinib in both relapsing-remitting and primary progressive MS. Those results have been submitted to the FDA for approval. This week, Dr. Jiwon Oh, the principal investigator in one of the Phase 3 trials for fenebrutinib, walks us through these positive results and explains what makes fenebrutinib a different kind of disease-modifying therapy and who might benefit most from it.   We're also talking about the European approval of Cenrifki (Tolebrutinib) to treat nonrelapsing secondary progressive MS, and we'll share our perspective on why the FDA should have -- and should still -- approve this DMT in the U.S. We'll tell you about two studies funded by the National MS Society that will focus on identifying links between menopause and MS. We'll share some sobering news about healthcare affordability in America. And we'll share some good news from the U.S. House Appropriations Committee, along with an opportunity for you to spend just 5 minutes doing some important advocacy work. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Fenebrutinib has been submitted to the FDA for approval  :22 Cenrifki (Tolebrutinib) approved in Europe for Nonrelapsing Secondary Progressive MS  1:09 National MS Society funds two studies to identify links between menopause and MS  4:19 Healthcare has become unaffordable for the majority of Americans  8:23 The U.S. House Appropriations Committee has approved $20 million in funding for the MS Research Program   11:57 Dr. Jiwon Oh explains why Fenebrutinib is a different kind of disease-modifying therapy, and who may benefit from it  15:36 Share this episode  32:22 Next week  32:43 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/461 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com PHASE 3 CLINICAL TRIAL: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis https://www.nejm.org/doi/abs/10.1056/NEJMoa2415988 VIDEO: Principal Investigator Dr. Robert Fox Discusses the Phase 3 clinical trial for Tolebrutinib in Nonrelapsing Secondary Progressive MS https://www.youtube.com/watch?v=tJQ93qdlXrU GALLUP POLL: U.S. Adults' Ability to Afford Healthcare at a Five-Year Low https://news.gallup.com/poll/710942/adults-ability-afford-healthcare-five-year-low.aspx JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 461 Guest: Dr. Jiwon Oh Privacy Policy

    34분
  3. Running Ireland with MS with Matt Knaggs and Colin Goodman

    6월 22일

    Running Ireland with MS with Matt Knaggs and Colin Goodman

    Next week, Matt Knaggs and Colin Goodman will attempt to set a Guinness World Record for running the 350-mile length of Ireland with MS. This week, you'll meet Matt and Colin and learn why this undertaking is so important to each of them.  We're also sharing survey results that point to gaps in how we approach MS care from the day of diagnosis. We'll tell you what it really means when you read that the prevalence of MS is increasing. It isn't bad news at all! We'll provide you with all the details you need to register for ECTRIMS Patient Community Day. And, if you can spare 20 minutes, we'll tell you how you can participate in an MS research study from the comfort of your own home. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're hitting the open road in Ireland with Matt Knaggs and Colin Goodman  :22 Survey points to gaps in how we approach MS care from day one  2:48 What does the increase in MS prevalence really mean?  8:48 Register for ECTRIMS 2026 Patient Community Day  12:33 An opportunity for you to participate in MS research without leaving home   14:10 Matt Knaggs and Colin Goodman talk about their attempt to set a Guinness World Record for running the length of Ireland with MS  15:56 Share this episode  32:13 Next week  32:33 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/460 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: Understanding the Unmet Needs of People with MS at Diagnosis and Throughout Their Care Journey: Insights from a Survey-Based Study https://link.springer.com/article/10.1007/s40120-026-00942-y STUDY: Drivers of Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022) https://www.neurology.org/doi/10.1212/WNL.0000000000218072 REGISTER: ECTRIMS 2026 Patient Community Day https://www.ectrimspatientcommunity.eu PARTICPATE IN RESEARCH: Survey: Automatic and Reflective Determinants, Fatigue, and Physical Activity for People with Multiple Sclerosis https://purdue.ca1.qualtrics.com/jfe/form/SV_douenJftXAcGxVk JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 460 Guest: Matt Knaggs, Colin Goodman Privacy Policy

    34분
  4. This Is Not Your Father's MS Rehabilitation with Dr. Brian Sandroff, Dr. Brad Willingham, and Dr. Laura Rice

    6월 15일

    This Is Not Your Father's MS Rehabilitation with Dr. Brian Sandroff, Dr. Brad Willingham, and Dr. Laura Rice

    For years, the standard medical advice for someone diagnosed with multiple sclerosis was simple, cautious, and as we now know, incredibly limiting: "Take it easy. Don't overexert yourself. And get plenty of rest."  Today, like almost every other aspect of MS care, neurological rehabilitation is being entirely rewritten. It's no longer about just managing decline; it's about leveraging emerging technologies to proactively build resilience, retrain the brain, and adopt cutting-edge exercise science to fundamentally change the trajectory of life with MS. This week, three experts share their thoughts on what MS rehabilitation looks like in 2026...and it's not your father's MS rehab! Dr. Brian Sandroff breaks down his groundbreaking research on how tailored exercise regimens—like treadmill walking—can actually improve memory, boost processing speed, and spark cognitive recovery. Dr. Brad Willingham discusses the game-changing world of continuous remote monitoring, explaining how wearable sensors and AI are turning real-world, 24/7 data into hyper-personalized, dynamic treatment plans. And Dr. Laura Rice delivers a practical exercise blueprint for individuals with MS who use wheelchairs. You'll learn how to jumpstart a safe fitness routine while effectively managing risks like heat sensitivity, shoulder overuse, skin breakdown, and the fear of falling. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're taking a deep dive into MS rehabilitation :22 Dr. Brian Sandroff answers the question, "Can exercise be used to treat cognitive impairment?"    2:10 Dr. Brad Willingham explains how AI can play a meaningful role in MS rehabilitation and clinical care  13:41 Dr. Laura Rice shares tips and strategies for exercising safely if you rely on a wheelchair for mobility   26:18 Share this episode  46:27 Next week  46:47 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/459 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 459 Guest: Dr. Brian Sandroff, Dr. Brad Willingham, and Dr. Laura Rice Privacy Policy

    48분
  5. From the 2026 CMSC Annual Meeting: Part Two with Dr. Stephen Krieger

    6월 8일

    From the 2026 CMSC Annual Meeting: Part Two with Dr. Stephen Krieger

    This week, our coverage of the Consortium of MS Centers annual meeting continues with my guest, Dr. Stephen Krieger. In a wide-ranging conversation, Dr. Krieger offers a very encouraging clinical trial update, shares his thoughts on what treating someone living with advanced MS ought to look like, and points out potential obstacles to implementing the updated criteria for diagnosing MS.  Dr. Krieger is a Professor of Neurology at the Icahn School of Medicine at Mount Sinai in New York, and a Multiple Sclerosis Specialist at the Corinne Coldsmith Dickinson Center for MS. We're also sharing results of a study that revealed some surprising connections between caffeine, alcohol, opioids, and MS symptoms. And if you're living with MS and you're the parent of a young child, we'll tell you about a book that belongs on your bookshelf. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're at the CMSC annual meeting with Dr. Stephen Krieger  :22 Study reveals the connection between caffeine, alcohol, and opioids and your MS symptoms    1:12 My Superhero with Wheels is the book you need if you're living with MS and have young children  5:15 Dr. Stephen Krieger discusses exciting clinical trial results, treating people with advanced MS, and potential challenges in implementing the updated criteria for diagnosing MS   8:39 Share this episode  30:22 Next week  30:41 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/458 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: Daily Temporal Associations Between Psychoactive Substances and Fatigue, Pain, Stress, and Depressive Symptoms in People with Multiple Sclerosis https://archives-pmr.org/article/S0003-9993(26)00035-3/fulltext BOOK: My Superhero with Wheels https://amazon.com/My-Superhero-wheels-True-Story/dp/B0GWVGSWX5/ref=sr_1_1 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 458 Guest: Dr. Stephen Krieger Privacy Policy

    32분
  6. From the 2026 CMSC Annual Meeting with Dr. Kathy Zackowski, Dr. Valerie Block, and Dr. Riley Bove

    6월 1일

    From the 2026 CMSC Annual Meeting with Dr. Kathy Zackowski, Dr. Valerie Block, and Dr. Riley Bove

    Last week, the Consortium of Multiple Sclerosis Centers, best known as CMSC, hosted its annual meeting in Charlotte, North Carolina, where we had a chance to talk with some of the world's top MS experts. We'll be sharing those conversations over the next few episodes of the podcast. Welcome to Part One of our coverage of CMSC 2026! In what has become an annual tradition at this conference, Dr. Kathy Zackowski, the National MS Society's Associate Vice-President of Research, joins me to share her impressions of the sessions and presentations that stood out to her. I also caught up with Dr. Valerie Block and Dr. Riley Bove on the first day of the CMSC annual meeting, and we discussed how wearable devices and digital tools are finding their way into MS care and how they can improve the quality of care for people living with MS. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're reporting from CMSC  :22 Dr. Kathy Zackowski shares the CMSC presentations that caught her eye  1:04 Dr. Valerie Block and Dr. Riley Bove discuss how wearable devices and digital tools are reshaping MS care  14:29 Share this episode  28:20 Next week  28:39 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/457 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 457 Guests: Dr. Kathy Zackowski, Dr. Valerie Block, Dr. Riley Bove Privacy Policy

    30분
  7. The First 100 Days Following Your MS Diagnosis with Dr. Nancy Sicotte

    5월 25일

    The First 100 Days Following Your MS Diagnosis with Dr. Nancy Sicotte

    May 30th is World MS Day! This year, the theme for World MS Day is "My MS Diagnosis," and I've been thinking about what happens right after that diagnosis. After an individual hears, "You have MS." This week, Dr. Nancy Sicotte joins me to discuss the things you should know, the things you should be thinking about, and the things you should be doing in the first 100 days following an MS diagnosis.  Dr. Sicotte is the Chair of Neurology and Director of Multiple Sclerosis and Neuroimmunology at Cedars-Sinai in Los Angeles, and she's the past Chair of the National MS Society's National Medical Advisory Committee.  We're also sharing results of a study that showed an exercise hormone protected neurons from inflammatory attack in a mouse model of MS. And we're sharing encouraging news about an experimental nasal spray that's been shown to delay disability progression and improve fatigue among people with non-active secondary progressive MS. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: World MS Day!  :22 Study reveals an exercise hormone has neuroprotective effects on a mouse model of MS    2:40 Tiziana shares evidence that Foralumab delays progression and improves fatigue in people with non-active secondary progressive MS  4:34 Dr. Nancy Sicotte looks at the first 100 days following an MS diagnosis  8:40 Share this episode  28:51 Next week  29:12 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/456 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com World MS Day Poster Maker https://worldmsday.org/poster-maker STUDY: The Exercise Hormone Irisin Has Neuroprotective Effects in a Mouse Model of Multiple Sclerosis https://www.nature.com/articles/s42255-026-01527-7 CLINICAL TRIAL: A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients https://clinicaltrials.gov/study/NCT06292923 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 456 Guest: Dr. Nancy Sicotte Privacy Policy

    30분
  8. MS and Your Oral Health with Dr. Ann Spolarich

    5월 18일

    MS and Your Oral Health with Dr. Ann Spolarich

    When we talk about managing Multiple Sclerosis, our conversations naturally focus on things like disease-modifying therapies, mobility, MRI scans, and symptom management. But in this week's episode, we're shining a light on a critical aspect of MS wellness that doesn't get nearly enough attention: your oral health. Living with MS can introduce a whole host of unexpected challenges to maintaining a healthy mouth. And beyond preventing tooth decay and gum disease, emerging research suggests that chronic oral inflammation, like periodontal disease, can trigger systemic inflammation throughout the body. Dr. Ann Spolarich joins us to break down the science, explain the risks, and offer practical suggestions for maintaining oral health for people living with MS and their care partners. We're also sharing study results that revealed 1,000 differences between immune cells in men and women. (And we're explaining why that's important) If you're a parent or caregiver for a child or teen with MS, we'll tell you everything you need to know about the FDA approval of Ocrevus for treating pediatric MS. We're sharing the details of an AI partnership designed to shorten the time to an MS diagnosis and track progression in real time. We're sharing the details of another AI partnership designed to test a pill that will ease MS-related depression and fatigue. And we'll tell you about a way that you can participate in MS research from the comfort and convenience of your own home. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: The connection between your oral health and MS  :22 Study reveals 1,000 differences between men's and women's immune cells    1:30 FDA approves Ocrevus for children over the age of 10 with relapsing remitting MS  3:28 An AI partnership designed to shorten the time to an MS diagnosis and track progression in real time  5:43 An AI partnership to test a pill that will ease MS-related depression and fatigue  9:24 An opportunity to participate in MS research from the comfort and convenience of your own home  13:16 Dr. Ann Spolarich discusses the connection between your oral health and MS  13:16 Share this episode  29:45 Next week  30:05 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/455 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: The Impact of Sex on the Immune System Explored at the Single-Cell Level https://www.cell.com/ajhg/fulltext/S0002-9297(26)00153-9 ONLINE SURVEY: Bladder-Related Fall Risk in People with MS https://www.nationalmssociety.org/how-you-can-help/get-involved/participate-in-research-studies/rs-bladder-fall-risk JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 455 Guest: Dr. Ann Spolarich Privacy Policy

    31분
모두 보기(516개)

소개

Jon Strum cuts through all the jargon and breaks down the latest multiple sclerosis news. You'll meet the scientists who are creating tomorrow's MS treatments today. You'll hear from the experts discussing how the latest tweaks and changes to our healthcare laws will impact your MS treatment. And we'll be talking to the courageous MS warriors who are out there advocating on behalf of the MS community every day, as well as the men and women who are committed to living their best lives with MS and living their best lives as MS caregivers. If you're dealing with multiple sclerosis in your life -- as a patient, caregiver, family member, or friend -- join us each week for RealTalk MS.

정보

  • 제작진
    Jon Strum
  • 방송 연도
    2017년 - 2026년
  • 에피소드
    516
  • 등급
    전체 연령 사용가
  • 저작권
    © Copyright 2026 All rights reserved.
  • 웹사이트 보기
    RealTalk MS

좋아할 만한 다른 항목